Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 23.87
-0.21 (-0.87%)
Sep 2, 2026, 3:04 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 2.75 billion as of September 1, 2026. Its market cap has increased by 6.40% in one year.
Market Cap
2.75B
Enterprise Value
4.07B
Revenue
650.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.87
ChartMarket Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 2.75B, a decrease of -58.14%. That is a compound annual growth rate of -14.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 2.75B | 21.37% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.07B |
| Beijing Kawin Technology Share-Holding | 3.01B |
| Shanghai Model Organisms Center | 2.98B |
| Zhejiang Shouxiangu Pharmaceutical | 2.93B |
| Shandong Sito Bio-technology | 2.79B |
| Landfar Bio-medicine | 2.77B |
| Guangdong VTR Bio-Tech | 2.74B |
| Shenzhen Bioeasy Biotechnology | 2.69B |